Showing results (5331-5340 of 5,703) with videos related to

Sort By:
Pageof 571
The Oncologist|March 25, 2016
Cardiotoxicity and Cardiac Monitoring During Adjuvant Trastuzumab in Daily Dutch Practice: A Study of the Southeast Netherlands Breast Cancer ConsortiumShanly C Seferina, Maaike de Boer, M Wouter Derksen, et al.
The Oncologist|March 30, 2016
Novel Treatments for Rare Cancers: The U.S. Orphan Drug Act Is Delivering-A Cross-Sectional AnalysisClemens Stockklausner, Anette Lampert, Georg F Hoffmann, et al.
The Oncologist|April 2, 2016
Membrane Localization of Human Equilibrative Nucleoside Transporter 1 in Tumor Cells May Predict Response to Adjuvant Gemcitabine in Resected Cholangiocarcinoma PatientsGiovanni Brandi, Marzia Deserti, Francesco Vasuri, et al.
The Oncologist|April 20, 2016
A Comparison of Proposed Biosimilar LA-EP2006 and Reference Pegfilgrastim for the Prevention of Neutropenia in Patients With Early-Stage Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Pegfilgrastim Randomized Oncology (Supportive Care) Trial to Evaluate Comparative Treatment (PROTECT-2), a Phase III, Randomized, Double-Blind TrialKimberly Blackwell, Roman Donskih, C Michael Jones, et al.
The Oncologist|April 8, 2016
Predictors of Timely Access of Oncology Services and Advanced-Stage Cancer in an HIV-Endemic SettingCarolyn A Brown, Gita Suneja, Neo Tapela, et al.
The Oncologist|April 8, 2016
Re-Evaluating Progression in an Era of Progress: A Review of First- and Second-Line Treatment Options in Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung CancerEmily H Castellanos, Leora Horn
The Oncologist|April 8, 2016
Efficacy and Safety of Everolimus in Extrapancreatic Neuroendocrine Tumor: A Comprehensive Review of LiteratureAntongiulio Faggiano, Pasqualino Malandrino, Roberta Modica, et al.
The Oncologist|July 30, 2017
TERT Promoter Hypermethylation in Gastrointestinal Cancer: A Potential Stool BiomarkerLi Liu, Cheng Liu, Omid Fotouhi, et al.
The Oncologist|August 3, 2017
A Phase II Study with Lead-In Safety Cohort of 5-Fluorouracil, Oxaliplatin, and Lapatinib in Combination with Radiation Therapy as Neoadjuvant Treatment for Patients with Localized HER2-Positive Esophagogastric AdenocarcinomasGregg Shepard, Edward R Arrowsmith, Patrick Murphy, et al.
The Oncologist|October 29, 2017
Individual Trade-Offs Between Possible Benefits and Risks of Cancer Treatments: Results from a Stated Preference Study with Patients with Multiple MyelomaDouwe Postmus, Sarah Richard, Nathalie Bere, et al.
Pageof 571